CIK 0000925741
- Non-accelerated filer
- Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232753988
- Phone
- +1 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Open-market buy President and CEO bought 300 shares at $9.00 ($2,700)
- 4 Open-market buy President and CEO bought 800 shares at an average $10.59 ($8,468)
- 4 Open-market buy President and CEO bought 400 shares at an average $9.95 ($3,979)
- 4 Open-market buy President and CEO bought 235 shares at an average $11.14 ($2,619)
- 4 Open-market buy President and CEO bought 2,000 shares at an average $1.02 ($2,039)
- 4 Open-market buy President and CEO bought 200 shares at $1.28 ($256)
- 4 Open-market buy President and CEO bought 2,100 shares at an average $1.15 ($2,422)
- 4 Open-market buy President and CEO bought 11,000 shares at an average $1.08 ($11,912)
- 4 Open-market buy President and CEO bought 50 shares at $1.59 ($80)
- 4/A Open-market buy Director bought 3,333,332 shares at $0.75 ($2,499,999)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Director bought 3,333,332 shares at $0.75 ($2,499,999)
- 4 Open-market buy 10% owner bought 2,000,000 shares at $0.75 ($1,500,000)
- 4 Open-market buy Director bought 3,333,332 shares at $0.75 ($2,499,999)
- 4 Open-market buy Director bought 1,000 shares at $2.10 ($2,102)
- 4 Open-market buy President and CEO bought 6,400 shares at an average $2.34 ($14,984)
- 4 Open-market buy Director bought 1,000 shares at $2.14 ($2,141)
- 4 Open-market buy President and CEO bought 3,900 shares at an average $2.16 ($8,412)
- 4 Open-market buy Director bought 1,000 shares at $2.10 ($2,100)
Page 14 of 23 · 442 filings